Download
document (85).pdf 765,90KB
WeightNameValue
1000 Titel
  • Correlations Between Interstitial Stromal Fibrillary Network And Disease Progression In Hepatitis C
1000 Autor/in
  1. Plesea, I.E. |
  2. Uscatu, C.D. |
  3. Serbanescu, M.S. |
  4. Indries, M. |
  5. Plesea, R.M. |
1000 Erscheinungsjahr 2016
1000 Publikationstyp
  1. Kongressschrift |
  2. Artikel |
1000 Online veröffentlicht
  • 2016-06-08
1000 Erschienen in
1000 Quellenangabe
  • 1(8):194
1000 Übergeordneter Kongress
1000 Copyrightjahr
  • 2016
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.17629/www.diagnosticpathology.eu-2016-8:194 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCtION / BACKGROUND: Since the virus description in the 80s [1] , [2], the infection with hepatitis virus C (HVC) became a real health problem because 50-80% of acute HVC infections evolve to chronic hepatitis, from which 4–20% of patients develop liver cirrhosis within 20 years and, finally, the risk of developing HCC of patients with liver cirrhosis is 1–5% per year [3]. The principal stage of pathological processes is the interstitial space and mainly the portal areas. Fibrillary network, one of the important components of the interstitial space, undergoes dramatic and highly variable changes, fibrosis representing one of the elements of the morphologic triad of the pathologic conflict within the liver parenchyma. AIMS: The aim of the study is to assess quantitatively the liver fibrosis on biopsy fragments of patients with virus C hepatitis (VCH) and to compare it with the fibrosis score described qualitatively in METAVIR system. METHODS: The studied material was represented by liver biopsies from 87 patients with VCH. Tissue fragments were processed following classical histological techniques (formalin fixation and paraffin embedment) and serial sections were stained, for each case, with Hematoxylin Eosin and Mason Trichrome. Tissue fragments images were acquired with a dedicated optical system, using the X10 objective and the portal and periportal areas were acquired using X20 objective. The fibrosis was firstly assessed using METAVIR qualitative score for fibrosis (MV-F1, MV-F2 and MV-F3). There were no cases with no fibrosis or with cirrhosis. The quantitative parameters determined were: total area of examined hepatic parenchyma, portal spaces area, total area of fibrosis and area of portal fibrosis. The quantitative parameters calculated were: the percentage of the total parenchymal area represented by fibrosis (TF/TA-HP), the percentage of the parenchymal area represented by the portal spaces (PS-A/TA-HP), the percentage of the portal spaces represented by the portal fibrosis (PS-F/PS-A). The measurements were made with two dedicated software programs, after preceding software calibration. For numerical parameters minimum (MIN), maximum (MAX) mean (AV) values and standard deviation (STDEV) were calculated. For comparison with METAVIR fibrosis score grades, the values of quantitative parameters calculated were stratified in classes. For statistical analysis of the correlation between the quantitative and qualitative assessment of fibrosis, t-test (2-sample, unequal variance), One-Way ANOVA test and χ2 test were used. RESULTS: TF/TA-HP and PS-A/TA-HP correlated with the METAVIR degrees of fibrosis (Figure 1). Both correlations were statistically validated at very high significance level. (Figure 2). In turn, PS-F/PS-A didn’t correlate with the METAVIR degrees of fibrosis, as statistical tests revealed (Figures 1 and 2).So, in VCH, one of the main morphological aspects is the constant enlargement of portal spaces but with a reduced extension of the destructive and reparatory processes towards the lobule center. Collagen fibers production is not an accelerated process, being in a relative equilibrium with the reactive inflammatory cellular population as demonstrated by the relatively constant percentage of the portal spaces represented by the fibrillary structures.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UGxlc2VhLCBJLkUu|https://frl.publisso.de/adhoc/uri/VXNjYXR1LCBDLkQu|https://frl.publisso.de/adhoc/uri/U2VyYmFuZXNjdSwgTS5TLg==|https://frl.publisso.de/adhoc/uri/SW5kcmllcywgTS4=|https://frl.publisso.de/adhoc/uri/UGxlc2VhLCBSLk0u
1000 Label
1000 Förderer
  1. Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6433126.rdf
1000 Erstellt am 2022-04-21T14:07:08.237+0200
1000 Erstellt von 218
1000 beschreibt frl:6433126
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet 2022-08-18T13:12:32.590+0200
1000 Objekt bearb. Mon May 16 10:57:35 CEST 2022
1000 Vgl. frl:6433126
1000 Oai Id
  1. oai:frl.publisso.de:frl:6433126 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source